1.Hemolytic Renal Damage during Cardiopulmonary Bypass and the Preventive Effect of Haptoglobin.
Koji NOMURA ; Hiromi KUROSAWA ; Kazuhiro HASHIMOTO ; Naoki MIYAMOTO ; Kazuhiko SUZUKI ; Hiroshi OKUYAMA ; Shigeki HORIKOSHI
Japanese Journal of Cardiovascular Surgery 1993;22(5):404-408
Renal damage caused by hemolysis during cardiopulmonary bypass (CPB) was investigated, and the preventive effects of haptoglobin in regard to this condition was also evaluated. Nineteen patients who underwent open heart surgery were divided into two groups: a control group (n=11) and a haptoglobin group (n=8). In the control group, the level of plasma-free hemoglobin increased significantly after CPB (p<0.01), and this level was strongly correlated with renal tubular leaking enzymes: NAG (r=0.76) and γ-GTP (r=0.81), in the Intensive Care Unit or on the first day after surgery. On the contrary, in the haptoglobin group, in which 4, 000 units of haptoglobin was added in the priming solution of CPB, no increased level of plasma free hemoglobin was observed. Furthermore, leak age of renal tubular enzymes were statistically less (p<0.05). It was concluded that free hemoglobin was a cause of renal damage during CPB and the damage was preventable by the administration of haptoglobin.
2.Modified Konno Operation for Aortic Valve Regurgitation after Arterial Switch Operation
Ken Nakamura ; Kiyozou Morita ; Yoshihiro Ko ; Katsushi Kinouchi ; Kazuhiro Hashimoto ; Hiromi Kurosawa
Japanese Journal of Cardiovascular Surgery 2007;36(2):72-75
We describe a case of postoperative aortic valve regurgitation (AR) after arterial awitch operation (ASO) successfully managed by the modified Konno procedure. A 4-year-old girl with complete transposition of the great arteries (TGA, Type II) had undergone the ASO (LeCompte maneuver) at 10 days of age. Because of progression of moderate AR 4 years after ASO, the modified Konno procedure with aortic valve replacement (SJM 21mm) was successfully performed. She remains in good clinical condition at the last follow-up at 5 years.
3.The efficacy of a novel integrated outside biliary stent and nasobiliary drainage catheter system for acute cholangitis: a single center pilot study
Naosuke KURAOKA ; Tetsuro UJIHARA ; Hiromi KASAHARA ; Yuto SUZUKI ; Shun SAKAI ; Satoru HASHIMOTO
Clinical Endoscopy 2023;56(6):795-801
Background/Aims:
Endoscopic biliary drainage is the gold standard treatment for cholangitis. The two methods of biliary drainage are endoscopic biliary stenting and nasobiliary drainage. A novel integrated outside biliary stent and nasobiliary drainage catheter system (UMIDAS NB stent; Olympus Medical Systems) was recently developed. In this study, we evaluated the efficacy of this stent in the treatment of cholangitis caused by common bile duct stones or distal bile duct strictures.
Methods:
We conducted a retrospective pilot study by examining the medical records of patients who required endoscopic biliary drainage for cholangitis due to common bile duct stones or distal bile duct strictures, and who were treated with a UMIDAS NB stent, between December 2021 and July 2022.
Results:
Records of 54 consecutive patients were reviewed. Technical and clinical success rates were 47/54 (87.0%) and 52/54 (96.3%), respectively. Adverse events were observed in 12 patients, with six patients experiencing pancreatitis as an adverse event, following endoscopic retrograde cholangiopancreatography (ERCP). Regarding late adverse events, five cases of biliary stent migration into the bile duct were observed. Disease-related death occurred in one patient.
Conclusions
The outside-type UMIDAS NB stent is an efficacious new method for biliary drainage and can be applied to many indications.
4.Prevalence of Complementary and Alternative Medicine Use in Ambulatory Patients with Urologic Disorders
Akiko MARUTANI ; Sachie MATUKI ; Rie HATTA ; Yoshie SAITO ; Tae HASHIMOTO ; Kazumi MIZUNO ; Hiromi TAKEUCHI ; Shizue TOMITA ; Satoshi OHNO ; Kazuto KOMATSU ; Mikio NAMIKI
Japanese Journal of Complementary and Alternative Medicine 2005;2(1):67-73
Objective: The prevalence of complementary and alternative medicine (CAM) in patients with various urologic disorders is unknown. We conducted the survey to determine the prevalence of CAM use in ambulatory patients.
Methods: We distributed questionnaires to 331 ambulatory patients with various urologic disorders in our department from March 10 to 31, 2004.
Results: One in third (30.5%) patients reported the use of at least one CAM. Patient age and gender were not associated with the frequency of the use of CAM. Although not statistically significant, patients with malignant disease showed a higher frequency of CAM use compared with patients with benign disease; 36.2% vs 27.0%, P=0.08. Among the CAM users, only 16 patients (15.8%) informed health care staff of their CAM use.
Conclusion: This result shows the current situation of CAM use in patients with urologic disorders. Because of the high prevalence, health care professionals should ask about patients' use of CAM.
5.The Effects of Carvedilol, a Vasodilating β-adrenoceptor Blocker, on the Quality of Life in Hypertensive Patients
Hiromi HASHIMOTO ; Tadashi OYAKE ; Toshio IKEDA ; Tomoko GOMI ; Masanori YOSHIDA ; Tetsuo FUJIMOTO ; Mitsuo UMEZU ; Kiichi NAGASHIMA ; Toshiharu FUJITA ; Michiko HORI ; Masayo TANAKA ; Makiko FUJII ; Mitsuo MATSUMOTO ; Yoshiaki MATSUMOTO ; Masamichi FUKUOKA ; Masao ISHI
Japanese Journal of Pharmacoepidemiology 1999;4(2):133-148
Objective : Carvedilol is a non-selective β blocker with an α blocking activity. Since this drug is highly fat-soluble, it can pass through the blood-brain barrier, and thus may induce depression and lower QOL. In the present study, physicians and pharmacists collaborated to evaluate the antihypertension effect of carvedilol and post-administration changes in QOL. Furthermore, the relationship between QOL and antihypertension effect was analyzed.
Design : Self-controlled study.
Patients and Methods : Subjects were outpatients with hypertension above the age of 70 years who visited one of 42 medical institutions in Japan between April 1995 and March 1996. A total of 243 patients were registered, and 10-20 mg of carvedilol was administered once a day for six months. Pharmacists assessed the QOL of these patients by asking 82 questions on three separate occasions : before administration and one and six months after administration. The antihypertensive effect of this drug was investigated in patients in whom all three QOL questionnaires were collected. The main test items were antihypertensive effect, changes in QOL (subjective QOL with a special emphasis on patient psychology), and the relationship between antihypertensive effect and QOL. The antihypertensive effect of this drug was statistically analyzed by a paired t-test, and changes in QOL were statistically analyzed using generalized estimating equations.
Results : All three QOL questionnaires were collected from a total of 146 patients. Their pre-administration systolic blood pressure was 159.6±1.4 mmHg, and diastolic blood pressure 94.0±0.9 mmHg, and their blood pressure decreased significantly one month after the start of administration. This antihypertensive effect of carvedilol persisted, and the systolic and diastolic blood pressure of these patients six months after the start of administration was 141.1±1.2 and 85.2±0.7 mmHg, respectively (significant decreases when compared to pre-administration levels ; both p<0.05).
Subjective QOL improved significantly after carvedilol administration. And, changes were not seen in sexual function. Changes in the five categories of subjective QOL were as follows : psychological stability, disease-induced inconvenience, and independence improved significantly after carvedilol administration, but changes were not seen in gratification or vitality. However, improvements in subjective QOL did not correlate with improvements in blood pressure.
Conclusions : The results of the present study showed that carvedilol improved QOL without negatively affecting sexual function. Subjective QOL reflects the psychological well-being of patients. In the present study, psychological stability, disease-induced inconvenience, and independence improved significantly, but changes were not seen in gratification or vitality. Since β blockers can suppress the central nervous system, they can reduce psychological stability, gratification and vitality. Even though carvedilol is highly fat-soluble, the results of non-clinical studies have shown that it does not suppress the central nervous system as much as propranolol. The results of the present study showed that carvedilol does not strongly suppress the central nervous system of humans. Moreover, significant changes in QOL were not seen between one and six months after the start of administration of carvedilol, suggesting that it is possible to estimate the QOL of patients on antihypertensive therapy after six months of administration by assessing their QOL one month after administration.
6.Experience of Recurrent/Advanced Cancer Patients Receiving Outpatient Cancer Rehabilitation
Utae KATSUSHIMA ; Yoshie IMAI ; Rieko HASHIMOTO ; Emi MIKI ; Hiromi ARAHORI ; Yuta INOUE ; Kimitaka HASE
Palliative Care Research 2022;17(4):127-134
The aim of this study was to clarify the experience of recurrent/advanced cancer patients receiving outpatient cancer rehabilitation and evaluate true endpoints of cancer rehabilitation. The study was conducted by semi-structured interviews of 13 recurrent/advanced patients undergoing cancer rehabilitation during cancer chemotherapy. Six categories were extracted: [Finding the physical condition suitable for me] [Being unable to find movements that I can effectively utilize myself] [Being able to continue normal everyday life] [Showing people around me that I can still move] [Having fun actively moving my body] [Gives meaning to my present “living”]. Cancer rehabilitation is considered to give patients with recurrent/advanced cancer a chance to adapt to their present predicament by helping them re-establish the meaning, value, and objective of living. These results suggest that acquiring mastery can be a new endpoint of cancer rehabilitation.
7.Factors Related to the Content of Consultation in the Cancer Nursing Outpatient Department of a Designated Cancer Care Hospital
Noriko TSUKAGOSHI ; Akemi TSUNODA ; Megumi WATANABE ; Ayumi KYOTA ; Maiko SENUMA ; Yuka KONDO ; Yoko KITADA ; Yoko HIROKAWARA ; Kei ICHIBA ; Yuka KANEKO ; Hiromi SEKINE ; Masae MIYAZAWA ; Tomomi HASHIMOTO
Palliative Care Research 2023;18(2):95-103
Purpose: The purpose of this study is to clarify the factors related to the content of consultation in the cancer nursing outpatient department of Gunma University Hospital. Method: A retrospective survey was conducted with 1084 cases, excluding the unknown cases, from 1308 consultations in FY2019. Survey items included age, gender, consulter, number of uses, treatment status, consultation content, etc. We conducted χ2 tests, and binomial logistic regression analysis between the content of the consultation and the attributes of the user. Results: The treatment-related content was associated with the following factors: 70s or older, family/relatives only, presence of recurrence/metastasis, first use, pre-treatment, urinary organs, uterine/ovary, and unknown primary. The body-related content was associated with the following factors: under treatment, post-treatment, no recurrence/metastasis, and digestive organs. The mental health-related content was associated with 30s or younger, 40s–60s, patient only, and second time or more. The social aspects-related content was associated with the following factors: patient only, family/relatives only, no recurrence/metastasis, and breast. Conclusion: The results reveal that associated factors differ by consultation content. These findings can be used to prepare for consultation based on the relevant associated factors.